We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
OmniAb Inc offers best-in-class therapeutic antibody discovery technologies. OmniAb Inc offers best-in-class therapeutic antibody discovery technologies.
Technical synergies between xPloration, OmniFlic®, OmniClic® and OmniDeep® enable new bispecific antibody discovery workflows for OmniAb’s partners OmniAb, Inc. (Nasdaq: OABI) today announced its...
Conference Call with Slides Begins at 4:30 p.m. Eastern Time Today OmniAb, Inc. (NASDAQ: OABI) today reported financial results for the three months ended March 31, 2024, and provided operating...
OmniAb, Inc. (NASDAQ: OABI) today announced that management will be participating in five investor conferences during the month of May. RBC Capital Markets Global Healthcare Conference, May 14-15...
OmniAb, Inc. (NASDAQ: OABI) will report financial results for the three months ended March 31, 2024 after the close of the U.S. financial markets on Thursday, May 9, 2024 and will hold a...
Conference Call with Slides Begins at 4:30 p.m. Eastern Time Today OmniAb, Inc. (NASDAQ: OABI) today reported financial results for the three and 12 months ended December 31, 2023, and provided...
OmniAb, Inc. (NASDAQ: OABI) will report financial results for the three and 12 months ended December 31, 2023 after the close of the U.S. financial markets on Wednesday, March 20, 2024 and will...
OmniAb, Inc. (NASDAQ: OABI) today announced that management will be participating in two upcoming investor conferences in March. TD Cowen 44th Annual Healthcare Conference, March 4-6, 2024, at...
Introduces the functionality and benefits of the first and only transgenic chicken producing single-domain antibodies to antibody industry thought leaders and research scientists from around the...
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.25 | -5.31914893617 | 4.7 | 4.76 | 4.415 | 509617 | 4.50088126 | CS |
| 4 | -0.22 | -4.71092077088 | 4.67 | 4.81 | 4.265 | 520895 | 4.56261843 | CS |
| 12 | -1.04 | -18.9435336976 | 5.49 | 6.5488 | 4.265 | 548309 | 5.10212415 | CS |
| 26 | -0.01 | -0.224215246637 | 4.46 | 6.715 | 4.21 | 516164 | 5.34875824 | CS |
| 52 | 0.57 | 14.6907216495 | 3.88 | 6.715 | 3.82 | 520442 | 5.15635013 | CS |
| 156 | -0.62 | -12.2287968442 | 5.07 | 6.715 | 1.91 | 732332 | 4.1169407 | CS |
| 260 | -0.62 | -12.2287968442 | 5.07 | 6.715 | 1.91 | 732332 | 4.1169407 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
